Frequency and Distribution of Candida Species from Denture Wearers

Species of Candida were isolated from 100 denture wearers, who were examined for grade of denture stomatitis, degree of denture plaque accumulation and other clinical features. Candida albicans was the dominant species isolated from denture surfaces followed by Torulopsis glabrata and Candida tropicalis. Statistical analysis of the results revealed close relationships between the grade of denture stomatitis and the degree of denture plaque accumulation or the fungal concentration on the denture surface, and also between the degree of denture plaque accumulation and fungal concentration on the denture surface. Furthermore, the grade of denture stomatitis correlated with the period of denture wearing but not with the patient's age. The fungal concentration on denture surface also correlated with the patient's age and the period of denture wearing

A Simplified Culture for the Diagnosis of Denture Stomatitis

The relationship between the clinical features of denture stomatitis and the number of Candida colonies determined by swabs from the palatal mucosa has been proved to be close. In daily practice, if the number of Candida organisms can be assessed present without both difficulty and need for special equipment, it might be of benefit. Therefore, a simplified culture has been developed for the diagnosis of denture stomatitis in the dental office, which is based on the acid-producing capacity of Candida species and is displayed in color changes. The coefficient of correlation between the culture reaction and the clinical assessment of denture stomatitis was r=-0.64 ~ -0.86. It has also been helpful in instructing patients about denture cleanliness.Stomastat® (Sankin Industry Co. Ltd., Osaka, Japan) and Candida Yellow Medium® (Fujiseiyakukogyo Co. Ltd., Tokyo, Japan) on the market are based on this research

Experimental and Chcal Study of Dose-Reducing Effect of Normal Tissues in Interstitial Radiotherapy of the Tongue Carcinom

本論文の要旨は平成3年6月の第24回広島大学歯学会総会において発表した

A Phase I Trial of 100mg/m2 Docetaxel in Patients with Advanced or Recurrent Breast Cancer

Docetaxel is a standard treatment for patients with advanced or recurrent breast cancer. The recommended dose is 60 to 100 mg/m2. Previous study have shown that the tumor response rates of patients who received docetaxel monotherapy at doses of 60, 75, and 100 mg/m2 were 22.1% , 23.3% , and 36.0% , respectively, and there was a significant relationship between the dose and response. In Europe and the United States, docetaxel is approved at a dose of 100 mg/m2, and Japanese guidelines also recommend a dose of 100 mg/m2. However, the approved dose in Japan is up to 75 mg/m2. We have launched a phase I trial evaluating 100 mg/m2 docetaxel in patients with advanced or relapsed breast cancer. The major eligibility criteria are as follows: age ≥20 years, pathologically diagnosed breast cancer, recurrent or advanced breast cancer, a good performance status, and HER2 [human epidermal growth factor receptor 2] negative. The primary endpoint is demonstrated safety of 100 mg/m2 docetaxel. This study will clarify whether 100mg/m2 docetaxel can be administrated safely in Japanese patients with advanced or recurrent breast cancer

Study protocol for a multi-center, randomized controlled trial to develop Japanese denture adhesive guidelines for patients with complete dentures : the Denture Adhesive Guideline trial : study protocol for a randomized controlled trial

Background: Denture adhesives, characterized as medical products in 1935 by the American Dental Association, have been considered useful adjuncts for improving denture retention and stability. However, many dentists in Japan are hesitant to acknowledge denture adhesives in daily practice because of the stereotype that dentures should be inherently stable, without the aid of adhesives. The aim of this study is to verify the efficacy of denture adhesives to establish guidelines for Japanese users. The null hypothesis is that the application of denture adhesives, including the cream and powder types, or a control (isotonic sodium chloride solution) would not produce different outcomes nor would they differentially improve the set outcomes between baseline and day 4 post-application. Methods: This ten-center, randomized controlled trial with parallel groups is ongoing. Three hundred edentulous patients with complete dentures will be allocated to three groups (cream-type adhesive, powder-type adhesive, and control groups). The participants will wear their dentures with the denture adhesive for 4 days, including during eight meals (three breakfasts, two lunches, and three dinners). The baseline measurements and final measurements for the denture adhesives will be performed on the first day and after breakfast on the fourth day. The primary outcome is a general satisfaction rating for the denture. The secondary outcomes are denture satisfaction ratings for various denture functions, occlusal bite force, resistance to dislodgement, masticatory performance, perceived chewing ability, and oral health-related quality of life. Between-subjects comparisons among the three groups and within-subjects comparisons of the pre- and post-intervention measurements will be performed. Furthermore, a multiple regression analysis will be performed. The main analyses will be based on the intention-to-treat principle. A sample size of 100 subjects per group, including an assumed dropout rate of 10 %, will be required to achieve 80 % power with a 5 % alpha level. Discussion: This randomized clinical trial will provide information about denture adhesives to complete denture wearers, prosthodontic educators, and dentists in Japan. We believe this new evidence on denture adhesive use from Japan will aid dentists in their daily practice even in other countries

Sophisticated Framework between Cell Cycle Arrest and Apoptosis Induction Based on p53 Dynamics

The tumor suppressor, p53, regulates several gene expressions that are related to the DNA repair protein, cell cycle arrest and apoptosis induction, which activates the implementation of both cell cycle arrest and induction of apoptosis. However, it is not clear how p53 specifically regulates the implementation of these functions. By applying several well-known kinetic mathematical models, we constructed a novel model that described the influence that DNA damage has on the implementation of both the G2/M phase cell cycle arrest and the intrinsic apoptosis induction via its activation of the p53 synthesis process. The model, which consisted of 32 dependent variables and 115 kinetic parameters, was used to examine interference by DNA damage in the implementation of both G2/M phase cell cycle arrest and intrinsic apoptosis induction. A low DNA damage promoted slightly the synthesis of p53, which showed a sigmoidal behavior with time. In contrast, in the case of a high DNA damage, the p53 showed an oscillation behavior with time. Regardless of the DNA damage level, there were delays in the G2/M progression. The intrinsic apoptosis was only induced in situations where grave DNA damage produced an oscillation of p53. In addition, to wreck the equilibrium between Bcl-2 and Bax the induction of apoptosis required an extreme activation of p53 produced by the oscillation dynamics, and was only implemented after the release of the G2/M phase arrest. When the p53 oscillation is observed, there is possibility that the cell implements the apoptosis induction. Moreover, in contrast to the cell cycle arrest system, the apoptosis induction system is responsible for safeguarding the system that suppresses malignant transformations. The results of these experiments will be useful in the future for elucidating of the dominant factors that determine the cell fate such as normal cell cycles, cell cycle arrest and apoptosis

Clinical Effect of Infusion Therapy in Combination with Local Antimycotic Drugs on Acute Pseudomembraneous Candidiasis Induced by Removable Dentures

Denture stomatitis is often observed in the denture-bearing mucosa. Candida albicans and related species are now believed to play a major role as a pathogenic factor in denture stomatitis. If systemic predisposing factors are present, denture stomatitis will sometimes develop into acute pseudomembraneous candidiasis. In acute pseudomembraneous candidiasis, the patients cannot take foods, and dehydration often occurs. This vicious cycle is the most important cause of increase in the growth of Candida species. Therefore, in order to improve the patient's physical condition, infusion therapy will be the first choice of treatment. The purpose of this study was to investigate the clinical effect of infusion therapy in combination with local antimycotic drugs on this type of candidiasis. We observed 4 cases of acute pseudomembraneous candidiasis induced by removable dentures and tried to treat these patients with infusion therapy (5% dextrose in lactatedRinger's solution) and local antimycotic drugs (Nystatin ointment or 1 % Miconazole nitrate cream). The acute inflammatory symptoms were significantly decreased by this therapy. The result of this study indicated that infusion therapy in combination with local antimycotic drugs was clinicaly effective on acute pseudomembraneous candidiasis induced by Candida-induced denture stomatitis

Pelapisan Gigi tiruan:Denture lining

xii,90 hlm

Pelapisan Gigi tiruan:Denture lining

xii,90 hlm